Beacon Pointe Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$649K Buy
10,129
+661
+7% +$37.9K 0.12% 139
2019
Q3
$479K Buy
9,468
+70
+0.7% +$3.29K 0.1% 161
2019
Q2
$429K Sell
9,398
-656
-7% -$30.6K 0.09% 174
2019
Q1
$479K Sell
10,054
-420
-4% -$20.9K 0.11% 158
2018
Q4
$544K Buy
+10,474
New +$563K 0.2% 122

Other funds holding BMY

Beacon Pointe Wealth Advisors's BMY Position: Q4 2019 in Review

Beacon Pointe Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 7% in Q4 2019, buying an estimated $37.9K and bringing the position to 10,129 shares worth $649K. The position accounts for 0.12% of the portfolio, ranked #139.

Beacon Pointe Wealth Advisors first reported a position in BMY in Q4 2018 and has held it in 5 quarters since. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Beacon Pointe Wealth Advisors held 10,129 shares of Bristol-Myers Squibb worth $649K as of Q4 2019.
  • Beacon Pointe Wealth Advisors bought 661 Bristol-Myers Squibb shares in Q4 2019, an estimated $37.9K.
  • Bristol-Myers Squibb made up 0.12% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #139 holding.
  • Beacon Pointe Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 5 quarters since.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.